ESRRA and neoplasm: Importantly, as observed in vitro, C29 potentiated the tumor suppressive effect of 5-azadC in vivo, thus validating the utility of combining ERRα and DNA methyltransferase inhibitors in the pharmacological intervention of BC (Fig. 5b, c).